Livermore

StemPoint Capital LP

SEC CIK
0001952142

Holdings, Q2 2026

Positions as of Jun 30, 2026, filed Aug 14, 2026.SEC

Positions
73
+3 vs. Q1 2026
Total value
$577.91M
−$454.85M (−44.0%) vs. Q1 2026

Compare with Q1 2026: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2026.

StemPoint Capital LP holdings in Q2 2026
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
TNGXTANGO THERAPEUTICS INCCOM1,223,019$38.23M6.62%+821,181+204.4%AddedView
ABVXABIVAX SASPONSORED ADS283,657$37.8M6.54%−343,925−54.8%ReducedView
RVMDREVOLUTION MEDICINES INCCOM159,943$29.95M5.18%−403,321−71.6%ReducedView
ERASERASCA INCCOM1,565,913$28.69M4.96%+1,086,191+226.4%AddedView
TYRATYRA BIOSCIENCES INCCOM632,754$20.21M3.50%+246,400+63.8%AddedView
DNTHDIANTHUS THERAPEUTICS INCCOM200,851$19.58M3.39%+29,847+17.5%AddedView
ELVNENLIVEN THERAPEUTICS INCCOM346,914$17.61M3.05%−379,962−52.3%ReducedView
MLYSMINERALYS THERAPEUTICS INCCOM602,686$16.26M2.81%−464,070−43.5%ReducedView
BHVNBIOHAVEN LTDCOM1,064,200$15.84M2.74%−2,124,782−66.6%ReducedView
SRZNSURROZEN INCCOM NEW602,798$13.79M2.39%−118,822−16.5%ReducedView
KNSAKINIKSA PHARMACEUTICALS INTLORD SHS CL A209,234$13.38M2.32%+209,234NewView
SRRKSCHOLAR ROCK HLDG CORPCOM239,146$13.15M2.28%−1,831,846−88.5%ReducedView
ALKSALKERMES PLCSHS248,015$12.99M2.25%+87,031+54.1%AddedView
TRAXFIRST TRACKS BIOTHERAPEUTICSORD SHS622,723$12.53M2.17%+622,723NewView
PRAXPRAXIS PRECISION MEDICINES ICOM NEW37,243$12.47M2.16%−75,291−66.9%ReducedView
ROIVROIVANT SCIENCES LTDSHS348,408$12.33M2.13%−423,192−54.8%ReducedView
BIOABIOAGE LABS INCCOM464,171$11.38M1.97%−213,137−31.5%ReducedView
CGONCG ONCOLOGY INCCOM159,349$11.32M1.96%−251,895−61.3%ReducedView
ORKAORUKA THERAPEUTICS INCCOM116,461$11.08M1.92%+116,461NewView
IMVTIMMUNOVANT INCCOM276,527$10.65M1.84%−1,216,461−81.5%ReducedView
CELCCELCUITY INCCOM98,203$10.27M1.78%−21,921−18.2%ReducedView
RLMDRELMADA THERAPEUTICS INCCOM1,460,093$10.1M1.75%+265,275+22.2%AddedView
CLYMCLIMB BIO INCCOM742,745$9.69M1.68%+742,745NewView
SYRESPYRE THERAPEUTICS INCCOM NEW106,926$9.49M1.64%−228,286−68.1%ReducedView
ZURAZURA BIO LTDCLASS A ORD SHS1,368,215$8.07M1.40%−138,825−9.2%ReducedView
IFRXINFLARX NVCOM3,228,255$7.23M1.25%+3,228,255NewView
AMLXAMYLYX PHARMACEUTICALS INCCOM384,304$6.9M1.19%−955,066−71.3%ReducedView
CLDXCELLDEX THERAPEUTICS INC NEWCOM NEW178,412$6.64M1.15%−330,122−64.9%ReducedView
OVIDOVID THERAPEUTICS INCCOM2,417,283$6.5M1.13%+2,417,283NewView
EQEQUILLIUM INCCOM2,016,607$6.45M1.12%+2,016,607NewView
DFTXDEFINIUM THERAPEUTICS INCCOM SHS137,124$6.45M1.12%−513,842−78.9%ReducedView
CYTKCYTOKINETICS INCCOM NEW75,603$6.44M1.11%−183,551−70.8%ReducedView
DMRADAMORA THERAPEUTICS INCCOM NEW216,194$5.62M0.97%+216,194NewView
IVAINVENTIVA SAADS1,426,320$5.39M0.93%+1,426,320NewView
IPSCCENTURY THERAPEUTICS INCCOM2,146,182$5.26M0.91%+2,146,182NewView
AURAAURA BIOSCIENCES INCCOM714,280$5.07M0.88%+714,280NewView
EYPTEYEPOINT INCCOM NEW338,471$4.84M0.84%−1,283,057−79.1%ReducedView
ASMBASSEMBLY BIOSCIENCES INCCOM NEW170,378$4.68M0.81%−200,492−54.1%ReducedView
WHWKWHITEHAWK THERAPEUTICS INCCOM1,021,037$4.68M0.81%−857,701−45.7%ReducedView
XENEXENON PHARMACEUTICALS INCCOM76,075$4.59M0.79%−205,435−73.0%ReducedView
QUREUNIQURE NVSHS88,115$4.06M0.70%−68,017−43.6%ReducedView
CMPSCOMPASS PATHWAYS PLCSPONSORED ADS284,769$4.03M0.70%+284,769NewView
AVLNAVALYN PHARMACEUTICALS INCCOM SHS118,000$3.88M0.67%+118,000NewView
MPLTMAPLIGHT THERAPEUTICS INCCOM106,906$3.83M0.66%−93,094−46.5%ReducedView
ALMSALUMIS INCCOM135,736$3.82M0.66%−323,396−70.4%ReducedView
AXSMAXSOME THERAPEUTICS INC.COM15,375$3.76M0.65%+15,375NewView
GLUEMONTE ROSA THERAPEUTICS INCCOM153,544$3.72M0.64%+153,544NewView
ACADACADIA PHARMACEUTICALS INCCOM143,167$3.62M0.63%−341,965−70.5%ReducedView
SLDBSOLID BIOSCIENCES INCCOM NEW358,780$3.58M0.62%−32,026−8.2%ReducedView
PSNLPERSONALIS INCCOM247,783$3.32M0.57%+247,783NewView
CBIOCRESCENT BIOPHARMA INC.COM182,382$3.28M0.57%+182,382NewView
ARWRARROWHEAD PHARMACEUTICALS INCOM39,198$3.2M0.55%+39,198NewView
KODKODIAK SCIENCES INCCOM75,872$2.96M0.51%+75,872NewView
PHVSPHARVARIS N VCOM80,907$2.8M0.48%−92,367−53.3%ReducedView
MNPRMONOPAR THERAPEUTICS INCCOM NEW30,125$2.79M0.48%+30,125NewView
RAPPRAPPORT THERAPEUTICS INCCOM66,582$2.77M0.48%+66,582NewView
NAMSNEWAMSTERDAM PHARMA COMPANYORDINARY SHARES77,589$2.63M0.46%−283,727−78.5%ReducedView
SIONSIONNA THERAPEUTICS INCCOM59,426$2.61M0.45%−13,654−18.7%ReducedView
ARQTARCUTIS BIOTHERAPEUTICS INCCOM98,945$2.59M0.45%−728,639−88.0%ReducedView
CCCCC4 THERAPEUTICS INCCOM STK523,648$2.45M0.42%−382,824−42.2%ReducedView
SPRBSPRUCE BIOSCIENCES INCCOM NEW41,388$2.23M0.39%+28,668+225.4%AddedView
CUECUE BIOPHARMA INCCOM66,995$2.11M0.37%+66,995NewView
GPCRSTRUCTURE THERAPEUTICS INCSPONSORED ADS38,178$2.05M0.35%−362,356−90.5%ReducedView
PTGXPROTAGONIST THERAPEUTICS INCCOM16,303$2M0.35%−128,851−88.8%ReducedView
HLXCHELIX ACQUISITION CORP IIIUSD CL A ORD SHS171,671$1.83M0.32%−438,385−71.9%ReducedView
BDSXBIODESIX INCCOM70,000$1.58M0.27%−70,008−50.0%ReducedView
TENXTENAX THERAPEUTICS INCCOM NEW96,273$1.4M0.24%−281,127−74.5%ReducedView
SABSSAB BIOTHERAPEUTICS INCCOM NEW342,631$1.34M0.23%−407,369−54.3%ReducedView
CALCCALCIMEDICA INCCOM NEW1,244,864$1.2M0.21%+1,244,864NewView
LBRXLB PHARMACEUTICALS INCCOM SHS31,785$1.03M0.18%−68,215−68.2%ReducedView
CLRBCELLECTAR BIOSCIENCES INCCOM NEW354,938$986.73K0.17%+354,938NewView
PRQRPROQR THRAPEUTICS N VSHS EURO431,054$801.76K0.14%+431,054NewView
VTGNVISTAGEN THERAPEUTICS INCCOM616,749$17.28K0.00%−616,749−50.0%ReducedView

Options (10)

Put and call positions reported in the same filing. The value is that of the underlying shares, as reported on Form 13F.

StemPoint Capital LP option positions in Q2 2026
SecurityClassPutsCalls
PSNLPERSONALIS INCCOM–$810.75K
STATE STREET SPDR S&P BIOTECH ETF78464A870ETF$400K$178K
BHVNBIOHAVEN LTDCOM–$525K
AZNASTRAZENECA PLC ORDADR–$180K
TNGXTANGO THERAPEUTICS INCCOM–$175K
RVMDREVOLUTION MEDICINES INCCOM$127.5K–
ERASERASCA INCCOM$90K–
ARK ETF TR00214Q302GENOMIC REV ETF$75K–
ROIVROIVANT SCIENCES LTDSHS$40K–
AMGNAMGEN INC COMStock$15K–

Sold out since Q1 2026 (22)

Positions held at the end of Q1 2026 that are no longer in this filing.

StemPoint Capital LP positions sold out since Q1 2026
SecurityClassShares, Q1 2026Value, Q1 2026% of portfolio, Q1 2026
SNDXSYNDAX PHARMACEUTICALS INCCOM2,431,486$56.8M5.50%
MBXMBX BIOSCIENCES INCCOM998,938$29.82M2.89%
DYNDYNE THERAPEUTICS INCCOM1,012,150$18.35M1.78%
EWTXEDGEWISE THERAPEUTICS INCCOM581,728$18.32M1.77%
DNLIDENALI THERAPEUTICS INCCOM853,122$16.38M1.59%
NRIXNURIX THERAPEUTICS INCCOM630,452$9.77M0.95%
EVMNEVOMMUNE INCCOM SHS387,554$8.77M0.85%
FTHSENSEI BIOTHERAPEUTICS INCCOM NEW265,746$8.38M0.81%
JNJJOHNSON & JOHNSON COMStock30,830$7.54M0.73%
XFORX4 PHARMACEUTICALS INCCOM NEW1,701,484$7.03M0.68%
PCVXVAXCYTE INCCOM118,122$6.86M0.66%
IVVDINVIVYD INCCOM3,749,092$4.87M0.47%
JBIOJADE BIOSCIENCES INCCOM NEW308,068$4.33M0.42%
TWSTTWIST BIOSCIENCE CORPCOM86,220$4.1M0.40%
AVTXAVALO THERAPEUTICS INCCOM NEW269,484$4.02M0.39%
IONSIONIS PHARMACEUTICALS INCCOM52,770$3.96M0.38%
IMCRIMMUNOCORE HLDGS PLCADS127,086$3.83M0.37%
FORTE BIOSCIENCES INC34962G208COM NEW116,040$3.01M0.29%
LPCNLIPOCINE INC NEWCOM NEW320,840$2.56M0.25%
EWEDWARDS LIFESCIENCES CORP COMStock29,176$2.34M0.23%
CAPRCAPRICOR THERAPEUTICS INCCOM NEW75,184$2.29M0.22%
STROSUTRO BIOPHARMA INCCOM SHS46,590$1.16M0.11%

13F filings by quarter

StemPoint Capital LP 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2026Aug 14, 202673$577.91Mvs. Q1 2026SEC
Q1 2026May 18, 2026Amended70$1.03Bvs. Q4 2025SECSEC
Q4 2025Feb 17, 202675$582.69Mvs. Q3 2025SEC
Q3 2025Nov 14, 202576$495.9Mvs. Q2 2025SEC
Q2 2025Aug 14, 202550$310.59Mvs. Q1 2025SEC
Q1 2025May 15, 202552$313.09Mvs. Q4 2024SEC
Q4 2024Feb 14, 202548$398.72Mvs. Q3 2024SEC
Q3 2024Nov 13, 202450$333.43Mvs. Q2 2024SEC
Q2 2024Aug 13, 2024Amended42$339.93Mvs. Q1 2024SEC
Q1 2024Aug 9, 2024Amended45$374.28Mvs. Q4 2023SEC
Q4 2023Feb 13, 202459$371.11M–SEC